This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Patient Safety Movement Foundation | |
|---|---|
| Name | Patient Safety Movement Foundation |
| Formation | 2012 |
| Founder | Joe Kiani |
| Type | Nonprofit organization |
| Headquarters | Irvine, California |
| Region served | Global |
Patient Safety Movement Foundation is a nonprofit organization founded in 2012 that advocates for reductions in preventable deaths in healthcare settings through technological innovation, policy advocacy, and data transparency. The foundation convenes hospitals, medical device manufacturers, academic centers, and policymakers to advance standardized safety protocols and measurable improvement. It emphasizes implementation of action-oriented solutions and public reporting to accelerate adoption across United States, United Kingdom, Saudi Arabia, India, and other international health systems.
The foundation was established in 2012 by entrepreneur and philanthropist Joe Kiani following involvement with ophthalmology device manufacturing and patient safety advocacy. Early activities included the inaugural annual Patient Safety, Science & Technology Summit, which brought together stakeholders from Johns Hopkins Hospital, Mayo Clinic, Cleveland Clinic, Stanford Health Care, and pharmaceutical and device firms such as Medtronic, Johnson & Johnson, and GE Healthcare. Over the 2010s the organization expanded from convening summits to developing the Open Patient Safety Network and the Patient Safety, Science & Technology Awards program, aligning with regulatory frameworks from the U.S. Food and Drug Administration, National Health Service, and international standards bodies like International Organization for Standardization.
The foundation's stated mission focuses on eliminating preventable deaths in hospitals and healthcare facilities by promoting adoption of evidence-based solutions drawn from clinical research at institutions such as Harvard Medical School, Massachusetts General Hospital, and Imperial College London. Goals include establishing measurable objectives similar to initiatives led by World Health Organization, advancing interoperability standards championed by Health Level Seven International, and fostering transparency akin to mandates under the Affordable Care Act. It seeks to accelerate translation of innovations developed at universities like University of California, San Francisco, Columbia University, and University of Oxford into routine clinical practice.
Key programs include the annual summit, a publication series of consensus action items, and collaborative projects such as the Open Data Initiative that aggregates adverse event metrics from participating systems including Kaiser Permanente, Intermountain Healthcare, and public health agencies. Initiatives promote medical device surveillance in partnership with registries like the National Surgical Quality Improvement Program and support implementation toolkits derived from research at Johns Hopkins Patient Safety Center and Brigham and Women's Hospital. The foundation also administers awards and fellowships recognizing innovators from institutions such as MIT, California Institute of Technology, and Carnegie Mellon University.
The organization has forged partnerships with academic medical centers, industry consortia, patient advocacy groups like Leapfrog Group and Consumers Union, and regulatory stakeholders including Centers for Medicare & Medicaid Services and the European Medicines Agency. Collaborations extend to professional societies such as the American Medical Association, American Nurses Association, American College of Surgeons, and specialty organizations like the Society of Critical Care Medicine. Global alliances include work with Pan American Health Organization, ministries of health in multiple countries, and technology partners from Intel, IBM Watson Health, and cloud providers.
Reported impacts include commitments from hundreds of hospitals to adopt specific Actionable Patient Safety Solutions and publication of benchmarked metrics informing safety interventions in areas such as perioperative management, sepsis recognition, and alarm fatigue reduction. Participating institutions such as Mount Sinai Health System and Penn Medicine have reported process changes attributed to collaboration through the foundation. The foundation's summits and policy briefs have influenced dialogues at venues including World Health Assembly and briefings with members of the United States Congress and national health authorities, contributing to adoption of reporting frameworks and clinical checklists modeled on prior successful programs like the Surgical Safety Checklist.
Governance is led by a board including healthcare executives, clinicians, and industry leaders drawn from organizations such as Stryker Corporation, Siemens Healthineers, and academic institutions. Funding sources comprise philanthropic contributions, industry sponsorships, foundation grants, and fee-based programs; major donors have included private philanthropists and corporate partners in the medical device and health technology sectors. The foundation reports operating relationships with certification and accreditation entities such as The Joint Commission while maintaining a nonprofit organizational structure.
Critics have raised concerns about potential conflicts of interest given industry funding from device manufacturers and technology firms, echoing debates seen in interactions between pharmaceutical industry funders and academic medicine at institutions like Yale School of Medicine. Questions have included the influence of corporate sponsors on agenda-setting at summits, transparency of data sources comparable to controversies around registries like MedSun, and the challenges of measuring causal attribution for reductions in preventable harm at systems including Veterans Health Administration. The organization has responded by publishing conflict-of-interest policies and emphasizing multi-stakeholder governance while debates continue in forums such as Health Affairs and specialty conferences.